We are thrilled to announce that MedGenome has been honored with the 2024 ASK Private Wealth HURUN INDIA Future Unicorn Award for Innovation in Genomics at the prestigious India Future Unicorn Awards, held on November 20, 2024, in Bengaluru. Our CFO, SURAJIT CHAKRABARTTY, had the privilege of accepting this award on behalf of the team at MedGenome. This recognition fuels our determination to continue pushing boundaries in the field of genomics and work tirelessly to fulfil our vision of making innovative genomic solutions affordable and accessible across the world. #MedGenome #Genetics #Innovation #InnovationInGenomics #IndiaFutureUnicornAwards
MEDGENOME
生物技术研究
Foster City，California 91,741 位关注者
Leader in Genetic Testing Services, Genomics Research and Drug Discovery Solutions
关于我们
MedGenome is a genomics-driven research and diagnostics company with a mission to improve global health by decoding the genetic information contained in an individual’s genome. Our powerful genomics solutions accelerate biomarker identification and discovery research for pharma and biotech companies. Our unique access to genomics data with clinical and phenotypic data provides insights into complex diseases at the genetic and molecular level to facilitate research in personalized healthcare. MedGenome Inc. has its Corporate Headquarters and a Next Generation Sequencing (NGS) lab in Foster City, California, US. MedGenome Labs is the market leader for genetic diagnostic testing in India and South Asia. We deliver AI-driven and Validated Genetic testing solutions through new-age proprietary tools and technologies to empower the Clinicians for better management of disease cohorts in rare inherited diseases, reproductive genetics, cancer, eye & neurological disorders, diabetes, cardiovascular diseases and more. Our Genetic Reference Lab at Bangalore is the largest CAP accredited lab in South-East Asia, that offers over 1300 genetic tests across different disease areas such as Oncology, Neurology, Cardiology, Ophthalmology and Rare diseases.
- 网站
-
https://www.medgenome.com
MEDGENOME的外部链接
- 所属行业
- 生物技术研究
- 规模
- 1,001-5,000 人
- 总部
- Foster City，California
- 类型
- 私人持股
- 创立
- 2013
- 领域
- Integrated Genomics Platform、Onsite next-generation sequencing、Population studies and panel assembly、Rescuing and repurposing compounds & biologics、WGS, WES、RNA Seq、miRNA Seq, ChIP Seq、MethylSeq, TCR Seq、NGS Bioinformatics和Immunotherapy Solutions
地点
MEDGENOME员工
动态
-
Around one-third of adults worldwide are regularly exposed to second-hand smoke which is just as dangerous as first-hand smoking and can cause Lung Cancer.?? Create a smoke-free environment. Protect your loved ones. To know more about Genetic tests for lung cancer patients, please write to us at [email protected] or call us at 1800 296 9696. #StopSmoking #MedGenome #Genetics #LungCancerAwareness #LungCancerPrevention #CancerPrevention #EarlyDetection #FightCancer
-
We are thrilled to present the third edition of our LinkedIn newsletter! At MedGenome, our unwavering commitment to bringing affordable genomic solutions more accessible is at the heart of everything we do. In line with this vision, our dedicated team has expanded our portfolio with new, cutting-edge tests, providing clinicians with even more powerful tools to improve the lives of the patients. This edition offers a deep dive into our scientific focus showcasing our research published in renowned journals, along with testimonials from clinicians who have experienced the benefits of our tests in shaping the diagnosis and treatment regime for their patients. We also share compelling case studies that highlight how our genetic tests have transformed the patient journey through early intervention. Additionally, we share how our work has been recognized in the media, both in India and globally. Don’t miss our special 10-year journey video, offering an exclusive look at the evolution of MedGenome, how we have grown over the past decade, and the driving force behind our mission. Stay connected with us and subscribe to receive the latest updates on cutting-edge advancements in genomics through #GenomeVerse. #MedGenome #Newsletter #GeneticTesting #Genetics #Genomics
-
Sepsis demands timely and accurate diagnosis to save lives, but antimicrobial resistance often complicates care. The Sepsis-AMR Panel by MedGenome equips clinicians with the precision needed to navigate these challenges. With a comprehensive detection panel, rapid turnaround, and CE-IVD-certified accuracy, it’s a step forward in delivering better outcomes for sepsis patients. Let’s make every moment count in critical care. For more information, reach out to us at [email protected] or 1800 296 9696 #SepsisCare #AntimicrobialResistance #PrecisionDiagnostics
-
CNVSure: Reliable Solution for CNV Confirmation Accurately confirms rare and small CNVs with our custom qPCR test. Faster, more flexible and cost-effective than traditional methods, CNVSure ensures precise results for even single exon deletions or duplications. Ideal for confirmation of CNVs detected?by NGS, CMA, and prenatal testing. #Genetics #Diagnostics #CNVs #Genomics